Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.
Garry CecconLazaros LazaridisGabriele StoffelsMarion RappManuel WeberTobias BlauPhillip LohmannSied KebirKen HerrmannGereon R FinkKarl-Josef LangenMartin GlasNorbert GalldiksPublished in: European journal of nuclear medicine and molecular imaging (2018)
FET PET may add valuable information in monitoring therapy in individual patients with high-grade glioma undergoing neurooncological treatment including TTFields.